# Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura

> **NCT00449540** · PHASE3 · COMPLETED · sponsor: **Neuralieve** · enrollment: 201 (actual)

## Conditions studied

- Migraine With Aura

## Interventions

- **DEVICE:** Active Transcranial Magnetic Stimulation (TMS) Device
- **DEVICE:** Sham TMS Device

## Key facts

- **NCT ID:** NCT00449540
- **Lead sponsor:** Neuralieve
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2011-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449540, "Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00449540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*